CompletedPhase 1NCT00588328
Official study title

The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning

Study summary

The purpose of this study is to find out whether a new device can help obtain more accurate CT and PET scans of the lungs and chest tumors and the liver and liver tumors to help in delivering radiation therapy. When we breathe, the amount of air in the lung changes. Lung tumors may also move during breathing. Liver tumors may also move with breathing; as the lungs inflate, the liver can be pushed down. A CT scan (a special type of X-ray) is routinely obtained as part of planning for lung or liver radiation therapy. Since patients breathe during this CT scan and their lung or liver tumors move, these CT scans can sometimes be inaccurate. We are now testing a device to only obtain the CT and an additional PET scan while patients are breathing in or out. This will hopefully allow us to deliver radiation with more accuracy.

Ask AI to explain this study
Start here

Key things to know

Main goalDiagnostic

This describes the study’s primary purpose.

What is being studiedPET/CT scan

The study team can explain what participation involves.

Who it may be forLung Cancer · Non-Hodgkin's Lymphoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 24, 2015 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 1

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Memorial Sloan Kettering Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Diagnostic
Study type
Interventional
Phase
Phase 1
Sponsor
Memorial Sloan Kettering Cancer Center
Interventions being studied
Device: PET/CT scan
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age ≥ 18 years old
  • Ability to sign informed consent form indicating investigative nature of this study, in keeping with the policies of the hospital.
  • Patients must have thoracic disease visible on a Chest CT scan, or liver disease visible on a abdominal CT scan.
Reasons someone may not be able to joinExclusion criteria
  • Pregnant women are ineligible. A pregnancy test will be performed on each fertile premenopausal female prior to entry into the study.
  • Patients with thoracic or liver disease that is not visible on CT scan
  • Patients who are unable to follow directions either due to language difficulties or hearing impairment.
  • Patients who are too ill to hold their breath.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Memorial Sloan-Kettering Cancer CenterNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 24, 2015. Always confirm current availability with the study team.

View original record ↗